Start here if you're new
what it is
Verisk sells data and software that help insurers manage risk across a $3.1B business.
how it gets paid
Last year Verisk Analytics made $3.1B in revenue. Underwriting solutions was the main engine at $1.2B, or 39% of sales.
why it's growing
Revenue grew 6.6% last year. Revenue was $779M, up 5.9%. adjusted EBITDA margin → profit left after operating costs before accounting charges → 56.1%.
what just happened
$1.82 beat the $1.53 estimate, and the quarter kept the model honest.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
80/100 earnings predictability — you can trust these numbers
32.4x trailing p/e — you're paying up for this one
0.9% dividend yield — cash in your pocket every quarter
28.5% return on capital — every dollar works hard here
xvary composite: 67/100 — average
What they do
Verisk sells data and software that help insurers manage risk across a $3.1B business.
Verisk has 7,800 employees and a 43.7% operating margin. operating margin → profit after running costs → 43.7% means 43.7 cents of every revenue dollar stays after expenses. That kind of spread makes switching painful for your insurer customers.
How they make money
$3.1B
annual revenue · their business grew +6.6% last year
Underwriting solutions
$1.2B
+8.7%
Claims analytics
$0.8B
+5.9%
Risk modeling
$0.5B
+6.0%
Fraud detection
$0.4B
+6.6%
Other legacy services
$0.2B
+0.0%
The products that matter
underwriting data and risk models
Underwriting Solutions
$556M in Q4 2025 · +8.7%
it generated $556M in Q4 2025, up 8.7% from a year ago. this is the segment carrying the growth case.
71% of segment mix
claims processing and fraud detection
Claims Solutions
$223M in Q4 2025 · flat
it produced $223M in Q4 2025 and was flat from a year ago. if this segment stays stalled, the company leans even harder on underwriting.
watch for reacceleration
Key numbers
$7.85
fy2027 eps est
$4B
fy2029 rev est
32.4x
trailing p/e
0.9%
dividend yield
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 2 — safer than 80% of stocks
- price stability 90 / 100
- long-term debt $3.2B (10% of capital)
- net profit margin 32.2% — keeps 32 cents of every dollar in revenue
- return on equity 50% — $0.50 profit for every $1 investors have put in
B++ with risk rank and net profit margin standing out. your money faces less risk here than at most public companies.
Total return vs. market
You invested $10,000 in VRSK 3 years ago → it's now worth $11,670.
The index would have given you $13,880.
source: institutional data · total return
What just happened
beat estimates
$1.82 beat the $1.53 estimate, and the quarter kept the model honest.
Revenue was $779M, up 5.9%. adjusted EBITDA margin → profit left after operating costs before accounting charges → 56.1%.
$779M
revenue
$1.82
eps
18.95%
surprise
the number that mattered
The 18.95% beat mattered because it says the business still outpaced the forecast machine.
-
verisk analytics has decided to keep the focus on its core insurance business.
-
after not hearing back from the federal trade commission with approval of the deal by the end of 2025, management terminated its proposed acquisition of acculynx.
-
the $2.9 billion transaction would have been a completely new market for the company.
-
the original announcement concerned investors and led to a drop in the share price.the purchase would have moved verisk into contractor scheduling and end-to-end workflow billing and material ordering for the roofing industry. this would have been a far extension from the core insurance-related data collection and analytics market. it might have provided new avenues of growth if successful, but certainly entailed significant risks in a new market.
-
acculynx is fighting to complete the merger and believes the termination is invalid.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is a slowdown in U.S. property & casualty premium growth.
med
premium growth cools
Verisk sells into the insurance workflow, and that workflow ultimately depends on premiums being written. If the $1.4T U.S. property & casualty market slows, Verisk’s 6–8% revenue growth plan gets harder to hit.
6–8% growth is the promise. slower premium growth makes that promise harder to keep.
med
claims stays flat
Claims Solutions generated $223M in Q4 2025 and was flat from a year ago. If that business doesn’t reaccelerate, Underwriting Solutions has to carry even more of the growth burden.
one of two major engines is already idling.
med
premium multiple meets ordinary growth
The stock trades at 32.4x trailing earnings while revenue grew 6.5% last year. You don’t need bad results for the stock to disappoint you. You just need steady to look slightly less steady.
this is a quality business, but the valuation already knows that.
At 32.4x earnings on 6.5% growth, a small slowdown can matter more than investors think.
source: institutional data · regulatory filings · risk analysis
Pay attention to
calendar
may 6, 2026 earnings report
the next print is the cleanest check on whether Q4’s 5.9% revenue growth was a baseline or a peak.
metric
Underwriting Solutions growth
watch whether the $556M segment can stay near its 8.7% pace. that is the main growth engine right now.
risk
Claims reacceleration
the $223M claims segment was flat. another flat quarter makes the business mix look more one-legged.
trend
buybacks versus organic growth
the $1.5B repurchase will help EPS. you still want revenue doing its part.
Analyst rankings
short-term outlook
average
momentum score 3. in human-speak: analysts see a stock acting normal, not breaking out.
risk profile
above average
stability score 2 — historically safer than roughly 80% of stocks.
chart momentum
below average
technical score 4. the chart is not doing you any favors from here.
earnings predictability
80 / 100
few surprise beats or misses. that’s good for trust, less good if you’re hoping for hidden upside.
source: institutional data
Institutional activity
457 buyers vs. 496 sellers in 3q2025. total institutional holdings: 0.1B shares.
source: institutional data
Price targets
3-5 year target range
$194
$355
$214
current price
$275
target midpoint · +28% from current · 3-5yr high: $395 (+85% · 17% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive